Lapatinib can accelerate cancer cell growth
The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab...
List view / Grid view
News
Wickham Laboratories to present at Cleanroom Technology Conference 2018
Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16 May at 2:30PM, at the National Conference Centre in Birmingham...
New UV-1900 UV-Vis Spectrophotometer
Industry's fastest level scan function and LabSolutions UV-Vis control software...
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Pill for breast cancer diagnosis may outperform mammograms
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
FDA approves Tafinlar/Mekinist for BRAF V600-mutant melanoma
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
FDA grants orphan drug designation to elamipretide for LHON
The FDA granted Orphan Drug Designation to elamipretide, for the treatment of Leber's hereditary optic neuropathy...
3-D printing is transforming care for congenital heart disease
3-D printing is an emerging technology that is impacting the way cardiologists treat patients with congenital heart disease...
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
Calcium-based MRI sensor enables more sensitive brain imaging
System detects direct signals of neural activity; could reveal patterns underlying behaviour...
Denosumab reduces glucocorticoid-induced bone loss
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients...
MS drug could reduce painful side effects of common cancer treatment
Researchers have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib...
Experimental arthritis drug prevents stem cell transplant complication
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants...
Researchers 3-D print electronics and cells directly on skin
Groundbreaking technology could help soldiers on the battlefield and people with skin disorders...
Porton Pharma Solutions and Codexis launch global partnership
Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business...
